ArticleBMJ open2021

ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19.

Kieran McCafferty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.